Digital biomarkers may lead to more robust clinical trials for rare diseases
- DHV-NET
- Sep 4, 2023
- 1 min read
However, work is still needed to validate their use for rare diseases

However, work is still needed to validate their use for rare diseases
Medical Device Development Tools (MDDT) | FDA https://www.fda.gov/medical-devices/medical-device-development-tools-mddt?utm_source=FDALin...
Walk, talk, think, see and feel: harnessing the power of digital biomarkers in healthcare | npj Digital Medicine (nature.com)...